Active Pharmaceutical Ingredients
Overview
Jubilant is a preferred partner of choice across the globe for innovator and generic pharmaceutical companies. Our Active Pharmaceutical Ingredients (APIs) business has a prominent presence in markets such as North America, South America, Europe, Japan, Asia Pacific (APAC), and the Middle East.
Jubilant offers one of the broadest portfolios comprising of more than 90 different APIs from various therapeutic categories such as CNS, CVS, anti-infective and anti-diabetic.
-
Proven expertise to operate large scale chemical operations, which is key to better cost efficiencies
-
Global leaders in Carbamazepine, Oxcarbazepine, Pinaverium, Risperidone, Valsartan.
-
Diversified & large external customer base to drive growth across multiple regions
-
Business sustainability & supply assurance from vertical integration of key APIs
-
Excellent compliance track record resulting from multiple inspections by various regulatory bodies.
-
World class APIs R&D team comprises of more than 150 synthesis and analytical scientists including PhDs; Expertise in complex chemistries such as Chiral separation, Low Temp reactions, Bio-transformation, Stereo-selective synthesis, continuous flow reactions; equipped with latest analytical instruments such as LC HRMS, NMR, XRD, LCMS. Analytical expertise in polymorphic characterization and contamination, Genetoxic and Carry over studies, Impurity profiling.
-
Dedicated DoE/QbD cell for bringing quality and process robustness during the product development.
Our world-class APIs R&D team comprises of more than 150 synthesis and analytical scientists, including PhDs.
